Bock E - Search Results

1

Discriminative power of an assay for automated in vitro screening of teratogens.

Walmod PS, Gravemann U, Nau H, Berezin V, Bock E. Walmod PS, et al. Among authors: bock e. Toxicol In Vitro. 2004 Aug;18(4):511-25. doi: 10.1016/j.tiv.2004.01.007. Toxicol In Vitro. 2004. PMID: 15130609

2

Automated in vitro screening of teratogens.

Walmod PS, Berezin A, Gallagher HC, Gravemann U, Lepekhin EA, Belman V, Bacon CL, Nau H, Regan CM, Berezin V, Bock E. Walmod PS, et al. Among authors: bock e. Toxicol Appl Pharmacol. 2002 May 15;181(1):1-15. doi: 10.1006/taap.2002.9393. Toxicol Appl Pharmacol. 2002. PMID: 12030837

3

Neural cell adhesion molecule-mediated neurite outgrowth is repressed by overexpression of HES-1.

Jessen U, Novitskaya V, Walmod PS, Berezin V, Bock E. Jessen U, et al. Among authors: bock e. J Neurosci Res. 2003 Jan 1;71(1):1-6. doi: 10.1002/jnr.10433. J Neurosci Res. 2003. PMID: 12478609

4

A peptide agonist of the neural cell adhesion molecule (NCAM), C3, protects against developmental defects induced by a teratogen pyrimethamine.

Klementiev B, Bichevaja N, Novikova T, Chebotar N, Bock E, Berezin V. Klementiev B, et al. Among authors: bock e. Int J Dev Neurosci. 2002 Nov;20(7):527-36. doi: 10.1016/s0736-5748(02)00086-2. Int J Dev Neurosci. 2002. PMID: 12485621

5

NCAM mimetic peptides: Pharmacological and therapeutic potential.

Berezin V, Bock E. Berezin V, et al. Among authors: bock e. J Mol Neurosci. 2004;22(1-2):33-39. doi: 10.1385/JMN:22:1-2:33. J Mol Neurosci. 2004. PMID: 14742908 Review.

6

Zippers make signals: NCAM-mediated molecular interactions and signal transduction.

Walmod PS, Kolkova K, Berezin V, Bock E. Walmod PS, et al. Among authors: bock e. Neurochem Res. 2004 Nov;29(11):2015-35. doi: 10.1007/s11064-004-6875-z. Neurochem Res. 2004. PMID: 15662836 Review.

7

The role of RhoA in the regulation of cell morphology and motility.

Tkach V, Bock E, Berezin V. Tkach V, et al. Among authors: bock e. Cell Motil Cytoskeleton. 2005 May;61(1):21-33. doi: 10.1002/cm.20062. Cell Motil Cytoskeleton. 2005. PMID: 15776463

8

Multiple effects of pentyl-4-yn-VPA enantiomers: from toxicity to short-term memory enhancement.

Gotfryd K, Owczarek S, Hoffmann K, Klementiev B, Nau H, Berezin V, Bock E, Walmod PS. Gotfryd K, et al. Among authors: bock e. Neuropharmacology. 2007 Mar;52(3):764-78. doi: 10.1016/j.neuropharm.2006.09.017. Epub 2006 Nov 7. Neuropharmacology. 2007. PMID: 17095022

9

Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation.

Gotfryd K, Skladchikova G, Lepekhin EA, Berezin V, Bock E, Walmod PS. Gotfryd K, et al. Among authors: bock e. BMC Cancer. 2010 Jul 21;10:383. doi: 10.1186/1471-2407-10-383. BMC Cancer. 2010. PMID: 20663132 Free PMC article.

10

The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities.

Gotfryd K, Hansen M, Kawa A, Ellerbeck U, Nau H, Berezin V, Bock E, Walmod PS. Gotfryd K, et al. Among authors: bock e. Basic Clin Pharmacol Toxicol. 2011 Sep;109(3):164-74. doi: 10.1111/j.1742-7843.2011.00702.x. Epub 2011 Apr 18. Basic Clin Pharmacol Toxicol. 2011. PMID: 21439023 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters